Skip to main content
News Directory 3
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Home
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Empowering Women and Girls on World AIDS Day: Key Strategies to Eradicate HIV/AIDS

Empowering Women and Girls on World AIDS Day: Key Strategies to Eradicate HIV/AIDS

November 27, 2024 Catherine Williams - Chief Editor Health

World AIDS Day 2024: Take the Rights Path

World AIDS Day occurs every year on December 1. It raises awareness about HIV and AIDS and promotes prevention, treatment, and care globally. The theme for 2024 is “Take the rights path.” This theme encourages a human rights approach to tackle inequalities that slow efforts to end AIDS.

Gender inequality is a major obstacle. In 2023, 62% of new HIV infections in Sub-Saharan Africa were among women and girls, with 44% of new infections globally.

Inequalities restrict women and girls from participating fully in society. Many face limited education about HIV. This lack of knowledge affects their ability to make safe choices during sex. Young women and girls are often at higher risk of HIV due to older sexual partners and harmful practices like child marriage.

Legal barriers also complicate the fight against HIV. Laws that criminalize HIV exposure or transmission increase stigma and discrimination, especially against marginalized groups, including women and girls. These factors make it harder for them to access health services for HIV prevention and treatment.

Pre-exposure prophylaxis (PrEP) is an effective method for preventing HIV. However, adherence can be challenging for women and girls due to distance from clinics, societal stigma, and concerns about healthcare providers being uninformed about PrEP.

Innovation in HIV prevention offers hope. Women-led solutions, such as the dapivirine vaginal ring, are discreet, effective, and safe for long-term use. This ring is compatible with most contraceptive methods, helping to prevent both pregnancy and HIV. Clinical successes with lenacapavir, a twice-yearly injectable drug, and cabotegravir, another injectable option, show promise for expanding prevention strategies for women and girls.

The future of PEPFAR is uncertain due to potential reauthorization challenges and shifting political landscapes. However, ongoing successes in addressing the issues surrounding HIV are encouraging. Focusing on women’s and girls’ needs within a human rights framework is essential for making progress in the fight against AIDS.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Search:

News Directory 3

ByoDirectory is a comprehensive directory of businesses and services across the United States. Find what you need, when you need it.

Quick Links

  • Copyright Notice
  • Disclaimer
  • Terms and Conditions

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

Connect With Us

© 2026 News Directory 3. All rights reserved.

Privacy Policy Terms of Service